On February 18, 2025 Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of next-generation blood purification therapies to address cancer and life-threatening infectious disease disorders, reported that Jim Joyce, the Company’s CEO will give a live presentation at tomorrow’s Emerging Growth Conference (Press release, Sigyn Therapeutics, FEB 18, 2025, View Source [SID1234650380]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: February 19th

Time: 4:10pm – 4:40pm Eastern

Registration: View Source;tp_key=a17d7ff4c2&sti=sigy

This will be a live, interactive online event where participants are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, View Source